Shares of Inovio Pharmaceuticals (INO) are heading back to $14 “in short order,” Andrew Left’s Citron Research predicted via Twitter. The stock in morning trading is up 16%, or $3.93, to $27.80. The firm know for short selling said via Twitter, “$INO has become a chew toy for RobinHood traders. Expect $INO back to $14 in short order This is the chart of $INO vs the 5 companies chosen by $CDC to lead vaccine. Even most spec $MRNA trades @ 27x vs. INO @ 158x. Trading can be profitable but vaccines are not.”